We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$36.9B
AUM Growth
+$1.94B
Cap. Flow
+$154M
Cap. Flow %
0.42%
Top 10 Hldgs %
4.62%
Holding
3,025
New
132
Increased
1,201
Reduced
1,478
Closed
188

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$57.1M
2
INCY icon
Incyte
INCY
+$53M
3
SD icon
SandRidge Energy
SD
+$46.7M
4
SNPS icon
Synopsys
SNPS
+$46.3M
5
AMD icon
Advanced Micro Devices
AMD
+$41.3M

Sector Composition

Rank Sector Weight
1 Technology 13.19%
2 Financials 13.13%
3 Healthcare 11.29%
4 Industrials 11.08%
5 Consumer Discretionary 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLP
2726
DELISTED
Cantaloupe
CTLP
$50K ﹤0.01%
+12,106
New +$51.3K
DRRX
2727
DELISTED
DURECT Corp
DRRX
$50K ﹤0.01%
4,834
+2,216
+85% +$23.7K
ACHN
2728
DELISTED
Achillion Pharmaceuticals
ACHN
$50K ﹤0.01%
11,987
-3,538
-23% -$14.7K
CPRX
2729
DELISTED
Catalyst Pharmaceutical
CPRX
$49K ﹤0.01%
24,984
+3,649
+17% +$4.65K
CDMO
2730
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$49K ﹤0.01%
10,755
+2,092
+24% +$7.01K
KNDI
2731
Kandi Technologies Group
KNDI
$67.5M
$47K ﹤0.01%
12,285
-1,840
-13% -$7.87K
RSYS
2732
DELISTED
Radisys Corp
RSYS
$45K ﹤0.01%
11,471
+4
+0% +$17
LEE icon
2733
Lee Enterprises
LEE
$172M
$43K ﹤0.01%
1,670
+500
+43% +$14.2K
IRD
2734
Opus Genetics
IRD
$306M
$42K ﹤0.01%
172
+29
+20% +$3.76K
INTX
2735
DELISTED
Intersections, Inc.
INTX
$42K ﹤0.01%
10,509
+63
+0.6% +$243
FBIO icon
2736
Fortress Biotech
FBIO
$104M
$41K ﹤0.01%
+747
New +$33.4K
LTRX icon
2737
Lantronix
LTRX
$240M
$41K ﹤0.01%
10,559
+63
+0.6% +$149
TLPH icon
2738
Talphera
TLPH
$66.4M
$41K ﹤0.01%
655
+126
+24% +$7.42K
ISEE
2739
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$40K ﹤0.01%
11,045
-407,675
-97% -$1.72M
WG
2740
DELISTED
Willbros Group
WG
$38K ﹤0.01%
13,821
+5
+0% +$15
VVUS
2741
DELISTED
Vivus Inc
VVUS
$37K ﹤0.01%
3,346
+1,290
+63% +$14.6K
IPI icon
2742
Intrepid Potash
IPI
$456M
$35K ﹤0.01%
2,027
+12
+0.6% +$232
III icon
2743
Information Services Group
III
$199M
$34K ﹤0.01%
10,786
+508
+5% +$1.67K
ALR
2744
DELISTED
AlerisLife Inc
ALR
$34K ﹤0.01%
1,585
+149
+10% +$3.65K
MVIS icon
2745
Microvision
MVIS
$6.21M
$31K ﹤0.01%
12,305
+73
+0.6% +$124
TLRA
2746
DELISTED
Telaria, Inc.
TLRA
$31K ﹤0.01%
15,615
+293
+2% +$657
NAVB
2747
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$31K ﹤0.01%
2,667
+171
+7% +$1.94K
CGNT
2748
DELISTED
Cogentix Medical, Inc.
CGNT
$31K ﹤0.01%
+16,968
New +$33.5K
CVRS
2749
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$30K ﹤0.01%
+22,453
New +$18.3K
ECYT
2750
DELISTED
Endocyte, Inc. Common Stock
ECYT
$30K ﹤0.01%
+11,728
New +$27.1K

Similar funds

Guggenheim Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Guggenheim Capital held 3,025 positions worth $36.9B, up 5.5% from $35B the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

Guggenheim Capital's Q1 2017 filing shows 132 new, 1,201 increased, 1,478 reduced and 188 closed positions. Its largest new stake was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,177,888 shares worth $26.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $92.1M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q1 2017 buy was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,177,888 shares worth $26.2M.
  • Guggenheim Capital added most to Idexx Laboratories in Q1 2017, an estimated $57.1M increase.
  • Guggenheim Capital's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92.1M.
  • Guggenheim Capital fully exited Linear Technology Corp in Q1 2017, selling an estimated $72.6M.
  • Guggenheim Capital's ten largest holdings make up 4.6% of its $36.9B portfolio in Q1 2017.
  • Guggenheim Capital opened 132 new positions and closed 188 in Q1 2017.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $36.9B.

Based on Guggenheim Capital's 13F filing for Q1 2017, filed 15 May 2017.